Latest Breaking News On - Biopharmaceutical development - Page 9 : comparemela.com

NanoSABER Probes Illuminate New Horizons in Cancer Imaging

In a groundbreaking development in cancer imaging, researchers from Johns Hopkins University have unveiled a pioneering approach to detecting and visualizing tumors with unprecedented precision.

Yue yuanBehnaz ghaemiIshan barmanKaruna singhJohns hopkinsJeffw bulteSwati tanwarPiyush rajLintong wuMegan craigMichaelt mcmahonWhiting school of engineeringJohns hopkins universityBiopharmaceutical developmentTechnology of chinaUniversity of science

Mesa Laboratories, Inc (MLAB) to Issue Quarterly Dividend of $0 16 on December 15th

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) declared a quarterly dividend on Tuesday, October 3rd, Zacks reports. Shareholders of record on Thursday, November 30th will be given a dividend of 0.16 per share by the medical instruments supplier on Friday, December 15th. This represents a $0.64 annualized dividend and a yield of 0.65%. The […]

United statesGarym owensJohn bradley schmiederAsia pacificMorgan stanleyCitadel advisorsDimensional fund advisorsBiopharmaceutical developmentGoldman sachs group incCalibration solutionsMesa laboratories incMesa laboratoriesGet free reportDirector john bradley schmiederFund advisorsGoldman sachs group

Mesa Laboratories (NASDAQ:MLAB) Sets New 12-Month Low at $99 31

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $99.31 and last traded at $101.13, with a volume of 888 shares trading hands. The stock had previously closed at $100.43. Analyst Upgrades and Downgrades Separately, StockNews.com assumed coverage on […]

United statesJohn bradley schmiederGarym owensAsia pacificMackenzie financial corpManufacturers life insurance companyBiopharmaceutical developmentCalibration solutionsMesa laboratories incPricet rowe associates incSecurities exchange commissionMesa laboratoriesGet free reportExchange commissionDirector john bradley schmiederFinancial corp

John Bradley Schmieder Sells 1,000 Shares of Mesa Laboratories, Inc (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) Director John Bradley Schmieder sold 1,000 shares of the company’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $123.74, for a total value of $123,740.00. Following the transaction, the director now directly owns 62,760 shares of the company’s […]

United statesAsia pacificJohn bradley schmiederMetlife investment managementCommonwealth of pennsylvania public school empls retrmtCitigroup incMesa laboratories incSecurities exchange commissionBlackrock incCalibration solutionsBiopharmaceutical developmentMesa laboratoriesGet free reportDirector john bradley schmiederExchange commissionBradley schmieder

Mesa Laboratories, Inc to Announce Second Quarter Results on November 6, 2023

Mesa Laboratories, Inc to Announce Second Quarter Results on November 6, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John sakysGary owensBiopharmaceutical developmentMesa laboratories incCalibration solutionsMesa laboratoriesDisinfection controlClinical genomics